Molecule Property Prediction
============================

.. include:: ../bibliography.rst

This page contains benchmarks of popular property prediction models.

We consider both vanilla random split and scaffold-based random split for molecule
data. The split for train/validation/test sets is 80%:10%:10%. For each model, we
evaluate it with 5 random splits and report the mean and the deviation of the
performance.

For datasets containing a lot of tasks, only the first 16 tasks are showed here due
to space limitations.

.. contents::
    :local:

Random Split
------------

QM9
^^^

.. image:: ../../../asset/benchmark/qm9_mae.png
.. image:: ../../../asset/benchmark/qm9_r2.png

QM8
^^^

.. image:: ../../../asset/benchmark/qm8_mae.png
.. image:: ../../../asset/benchmark/qm8_r2.png

BACE
^^^^

.. image:: ../../../asset/benchmark/bace_auroc.png
.. image:: ../../../asset/benchmark/bace_auprc.png

BBBP
^^^^

.. image:: ../../../asset/benchmark/bbbp_auroc.png
.. image:: ../../../asset/benchmark/bbbp_auprc.png

CEP
^^^

.. image:: ../../../asset/benchmark/cep_mae.png
.. image:: ../../../asset/benchmark/cep_r2.png

HIV
^^^

.. image:: ../../../asset/benchmark/hiv_auroc.png
.. image:: ../../../asset/benchmark/hiv_auprc.png

ClinTox
^^^^^^^

.. image:: ../../../asset/benchmark/clintox_auroc.png
.. image:: ../../../asset/benchmark/clintox_auprc.png

ESOL
^^^^

.. image:: ../../../asset/benchmark/esol_mae.png
.. image:: ../../../asset/benchmark/esol_r2.png

FreeSolv
^^^^^^^^

.. image:: ../../../asset/benchmark/freesolv_mae.png
.. image:: ../../../asset/benchmark/freesolv_r2.png

Lipophilicity
^^^^^^^^^^^^^

.. image:: ../../../asset/benchmark/lipophilicity_mae.png
.. image:: ../../../asset/benchmark/lipophilicity_r2.png

SIDER
^^^^^

.. image:: ../../../asset/benchmark/sider_auroc.png
.. image:: ../../../asset/benchmark/sider_auprc.png

Tox21
^^^^^

.. image:: ../../../asset/benchmark/tox21_auroc.png
.. image:: ../../../asset/benchmark/tox21_auprc.png

ToxCast
^^^^^^^

.. image:: ../../../asset/benchmark/toxcast_auroc.png
.. image:: ../../../asset/benchmark/toxcast_auprc.png

MUV
^^^

.. image:: ../../../asset/benchmark/muv_auroc.png
.. image:: ../../../asset/benchmark/muv_auprc.png


Malaria
^^^^^^^

.. image:: ../../../asset/benchmark/malaria_mae.png
.. image:: ../../../asset/benchmark/malaria_r2.png

Scaffold Split
--------------

QM9
^^^

.. image:: ../../../asset/benchmark/qm9_scaffold_mae.png
.. image:: ../../../asset/benchmark/qm9_scaffold_r2.png

QM8
^^^

.. image:: ../../../asset/benchmark/qm8_scaffold_mae.png
.. image:: ../../../asset/benchmark/qm8_scaffold_r2.png

BACE
^^^^

.. image:: ../../../asset/benchmark/bace_scaffold_auroc.png
.. image:: ../../../asset/benchmark/bace_scaffold_auprc.png

BBBP
^^^^

.. image:: ../../../asset/benchmark/bbbp_scaffold_auroc.png
.. image:: ../../../asset/benchmark/bbbp_scaffold_auprc.png

CEP
^^^

.. image:: ../../../asset/benchmark/cep_scaffold_mae.png
.. image:: ../../../asset/benchmark/cep_scaffold_r2.png

HIV
^^^

.. image:: ../../../asset/benchmark/hiv_scaffold_auroc.png
.. image:: ../../../asset/benchmark/hiv_scaffold_auprc.png

ClinTox
^^^^^^^

.. image:: ../../../asset/benchmark/clintox_scaffold_auroc.png
.. image:: ../../../asset/benchmark/clintox_scaffold_auprc.png

ESOL
^^^^

.. image:: ../../../asset/benchmark/esol_scaffold_mae.png
.. image:: ../../../asset/benchmark/esol_scaffold_r2.png

FreeSolv
^^^^^^^^

.. image:: ../../../asset/benchmark/freesolv_scaffold_mae.png
.. image:: ../../../asset/benchmark/freesolv_scaffold_r2.png

Lipophilicity
^^^^^^^^^^^^^

.. image:: ../../../asset/benchmark/lipophilicity_scaffold_mae.png
.. image:: ../../../asset/benchmark/lipophilicity_scaffold_r2.png

SIDER
^^^^^

.. image:: ../../../asset/benchmark/sider_scaffold_auroc.png
.. image:: ../../../asset/benchmark/sider_scaffold_auprc.png

Tox21
^^^^^

.. image:: ../../../asset/benchmark/tox21_scaffold_auroc.png
.. image:: ../../../asset/benchmark/tox21_scaffold_auprc.png

ToxCast
^^^^^^^

.. image:: ../../../asset/benchmark/toxcast_scaffold_auroc.png
.. image:: ../../../asset/benchmark/toxcast_scaffold_auprc.png

MUV
^^^

.. image:: ../../../asset/benchmark/muv_scaffold_auroc.png
.. image:: ../../../asset/benchmark/muv_scaffold_auprc.png

Malaria
^^^^^^^

.. image:: ../../../asset/benchmark/malaria_scaffold_mae.png
.. image:: ../../../asset/benchmark/malaria_scaffold_r2.png